APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pembrolizumab

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Pembrolizumab Market Analysis and Forecast 2026-2032

23 December 2025199 pages

Choose your research edition.

Industry ResearchPembrolizumab Industry Research Report 2026110 pages · $2,950 USDIndustry Growth & TrendsGlobal Pembrolizumab Industry Growth and Trends Forecast to 203273 pages · $3,450 USDMarket StructureGlobal Pembrolizumab Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032176 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pembrolizumab Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Pembrolizumab Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Pembrolizumab market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Pembrolizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Pembrolizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Pembrolizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Pembrolizumab is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Pembrolizumab include Merck. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Pembrolizumab, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Pembrolizumab, also provides the sales of main regions and countries. Of the upcoming market potential for Pembrolizumab, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Pembrolizumab sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Pembrolizumab market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Pembrolizumab sales, projected growth trends, production technology, application and end-user industry.

Pembrolizumab Segment by Company

Merck

Pembrolizumab Segment by Type

50mg Injection

100mg Injection

Pembrolizumab Segment by Application

Unresectable or Metastatic Solid Tumor

Advanced Melanoma

Head and Neck Squamous Cell Carcinoma (HNSCC)

Others

Pembrolizumab Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pembrolizumab market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pembrolizumab and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pembrolizumab.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Pembrolizumab in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Pembrolizumab manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pembrolizumab sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Pembrolizumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 50mg Injection Major Manufacturers Table 3. 100mg Injection Major Manufacturers Table 4. Global Pembrolizumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Unresectable or Metastatic Solid Tumor Major Manufacturers Table 6. Advanced Melanoma Major Manufacturers Table 7. Head and Neck Squamous Cell Carcinoma (HNSCC) Major Manufacturers Table 8. Others Major Manufacturers Table 9. Pembrolizumab Industry Trends Table 10. Pembrolizumab Industry Drivers Table 11. Pembrolizumab Industry Opportunities and Challenges Table 12. Pembrolizumab Industry Restraints Table 13. Global Pembrolizumab Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Pembrolizumab Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Pembrolizumab Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Pembrolizumab Revenue Market Share by Region (2021-2026) Table 17. Global Pembrolizumab Revenue Market Share by Region (2027-2032) Table 18. Global Pembrolizumab Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k pcs) Table 19. Global Pembrolizumab Sales by Region (2021-2026) & (k pcs) Table 20. Global Pembrolizumab Sales by Region (2027-2032) & (k pcs) Table 21. Global Pembrolizumab Sales Market Share by Region (2021-2026) Table 22. Global Pembrolizumab Sales Market Share by Region (2027-2032) Table 23. Global Pembrolizumab Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Pembrolizumab Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Pembrolizumab Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Pembrolizumab Sales Market Share by Manufacturers (2021-2026) Table 27. Global Pembrolizumab Sales Price (US$/pcs) of Manufacturers (2021-2026) Table 28. Global Pembrolizumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Pembrolizumab Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Pembrolizumab Manufacturers, Product Type & Application Table 31. Global Pembrolizumab Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Pembrolizumab by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Pembrolizumab Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Pembrolizumab Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Pembrolizumab Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Pembrolizumab Revenue Market Share by Type (2021-2026) Table 38. Global Pembrolizumab Revenue Market Share by Type (2027-2032) Table 39. Global Pembrolizumab Sales by Type 2021 VS 2025 VS 2032 (k pcs) Table 40. Global Pembrolizumab Sales by Type (2021-2026) & (k pcs) Table 41. Global Pembrolizumab Sales by Type (2027-2032) & (k pcs) Table 42. Global Pembrolizumab Sales Market Share by Type (2021-2026) Table 43. Global Pembrolizumab Sales Market Share by Type (2027-2032) Table 44. Global Pembrolizumab Price by Type (2021-2026) & (US$/pcs) Table 45. Global Pembrolizumab Price by Type (2027-2032) & (US$/pcs) Table 46. Global Pembrolizumab Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Pembrolizumab Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Pembrolizumab Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Pembrolizumab Revenue Market Share by Application (2021-2026) Table 50. Global Pembrolizumab Revenue Market Share by Application (2027-2032) Table 51. Global Pembrolizumab Sales by Application 2021 VS 2025 VS 2032 (k pcs) Table 52. Global Pembrolizumab Sales by Application (2021-2026) & (k pcs) Table 53. Global Pembrolizumab Sales by Application (2027-2032) & (k pcs) Table 54. Global Pembrolizumab Sales Market Share by Application (2021-2026) Table 55. Global Pembrolizumab Sales Market Share by Application (2027-2032) Table 56. Global Pembrolizumab Price by Application (2021-2026) & (US$/pcs) Table 57. Global Pembrolizumab Price by Application (2027-2032) & (US$/pcs) Table 58. Merck Company Information Table 59. Merck Business Overview Table 60. Merck Pembrolizumab Sales (k pcs), Revenue (US$ Million), Price (US$/pcs) and Gross Margin (2021-2026) Table 61. Merck Pembrolizumab Product Portfolio Table 62. Merck Recent Development Table 63. North America Pembrolizumab Revenue by Type (2021-2026) & (US$ Million) Table 64. North America Pembrolizumab Revenue by Type (2027-2032) & (US$ Million) Table 65. North America Pembrolizumab Sales by Type (2021-2026) & (k pcs) Table 66. North America Pembrolizumab Sales by Type (2027-2032) & (k pcs) Table 67. North America Pembrolizumab Sales Price by Type (2021-2026) & (US$/pcs) Table 68. North America Pembrolizumab Sales Price by Type (2027-2032) & (US$/pcs) Table 69. North America Pembrolizumab Revenue by Application (2021-2026) & (US$ Million) Table 70. North America Pembrolizumab Revenue by Application (2027-2032) & (US$ Million) Table 71. North America Pembrolizumab Sales by Application (2021-2026) & (k pcs) Table 72. North America Pembrolizumab Sales by Application (2027-2032) & (k pcs) Table 73. North America Pembrolizumab Sales Price by Application (2021-2026) & (US$/pcs) Table 74. North America Pembrolizumab Sales Price by Application (2027-2032) & (US$/pcs) Table 75. North America Pembrolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 76. North America Pembrolizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 77. North America Pembrolizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 78. North America Pembrolizumab Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 79. North America Pembrolizumab Sales by Country (2021-2026) & (k pcs) Table 80. North America Pembrolizumab Sales by Country (2027-2032) & (k pcs) Table 81. North America Pembrolizumab Sales Price by Country (2021-2026) & (US$/pcs) Table 82. North America Pembrolizumab Sales Price by Country (2027-2032) & (US$/pcs) Table 83. United States Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 84. Canada Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 85. Mexico Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 86. Europe Pembrolizumab Revenue by Type (2021-2026) & (US$ Million) Table 87. Europe Pembrolizumab Revenue by Type (2027-2032) & (US$ Million) Table 88. Europe Pembrolizumab Sales by Type (2021-2026) & (k pcs) Table 89. Europe Pembrolizumab Sales by Type (2027-2032) & (k pcs) Table 90. Europe Pembrolizumab Sales Price by Type (2021-2026) & (US$/pcs) Table 91. Europe Pembrolizumab Sales Price by Type (2027-2032) & (US$/pcs) Table 92. Europe Pembrolizumab Revenue by Application (2021-2026) & (US$ Million) Table 93. Europe Pembrolizumab Revenue by Application (2027-2032) & (US$ Million) Table 94. Europe Pembrolizumab Sales by Application (2021-2026) & (k pcs) Table 95. Europe Pembrolizumab Sales by Application (2027-2032) & (k pcs) Table 96. Europe Pembrolizumab Sales Price by Application (2021-2026) & (US$/pcs) Table 97. Europe Pembrolizumab Sales Price by Application (2027-2032) & (US$/pcs) Table 98. Europe Pembrolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. Europe Pembrolizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 100. Europe Pembrolizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 101. Europe Pembrolizumab Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 102. Europe Pembrolizumab Sales by Country (2021-2026) & (k pcs) Table 103. Europe Pembrolizumab Sales by Country (2027-2032) & (k pcs) Table 104. Europe Pembrolizumab Sales Price by Country (2021-2026) & (US$/pcs) Table 105. Europe Pembrolizumab Sales Price by Country (2027-2032) & (US$/pcs) Table 106. Germany Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 107. France Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 108. U.K. Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 109. Italy Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 110. Russia Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 111. Spain Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 112. Netherlands Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 113. Switzerland Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 114. Sweden Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 115. Poland Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 116. China Pembrolizumab Revenue by Type (2021-2026) & (US$ Million) Table 117. China Pembrolizumab Revenue by Type (2027-2032) & (US$ Million) Table 118. China Pembrolizumab Sales by Type (2021-2026) & (k pcs) Table 119. China Pembrolizumab Sales by Type (2027-2032) & (k pcs) Table 120. China Pembrolizumab Sales Price by Type (2021-2026) & (US$/pcs) Table 121. China Pembrolizumab Sales Price by Type (2027-2032) & (US$/pcs) Table 122. China Pembrolizumab Revenue by Application (2021-2026) & (US$ Million) Table 123. China Pembrolizumab Revenue by Application (2027-2032) & (US$ Million) Table 124. China Pembrolizumab Sales by Application (2021-2026) & (k pcs) Table 125. China Pembrolizumab Sales by Application (2027-2032) & (k pcs) Table 126. China Pembrolizumab Sales Price by Application (2021-2026) & (US$/pcs) Table 127. China Pembrolizumab Sales Price by Application (2027-2032) & (US$/pcs) Table 128. Asia Pembrolizumab Revenue by Type (2021-2026) & (US$ Million) Table 129. Asia Pembrolizumab Revenue by Type (2027-2032) & (US$ Million) Table 130. Asia Pembrolizumab Sales by Type (2021-2026) & (k pcs) Table 131. Asia Pembrolizumab Sales by Type (2027-2032) & (k pcs) Table 132. Asia Pembrolizumab Sales Price by Type (2021-2026) & (US$/pcs) Table 133. Asia Pembrolizumab Sales Price by Type (2027-2032) & (US$/pcs) Table 134. Asia Pembrolizumab Revenue by Application (2021-2026) & (US$ Million) Table 135. Asia Pembrolizumab Revenue by Application (2027-2032) & (US$ Million) Table 136. Asia Pembrolizumab Sales by Application (2021-2026) & (k pcs) Table 137. Asia Pembrolizumab Sales by Application (2027-2032) & (k pcs) Table 138. Asia Pembrolizumab Sales Price by Application (2021-2026) & (US$/pcs) Table 139. Asia Pembrolizumab Sales Price by Application (2027-2032) & (US$/pcs) Table 140. Asia Pembrolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 141. Asia Pembrolizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 142. Asia Pembrolizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 143. Asia Pembrolizumab Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 144. Asia Pembrolizumab Sales by Country (2021-2026) & (k pcs) Table 145. Asia Pembrolizumab Sales by Country (2027-2032) & (k pcs) Table 146. Asia Pembrolizumab Sales Price by Country (2021-2026) & (US$/pcs) Table 147. Asia Pembrolizumab Sales Price by Country (2027-2032) & (US$/pcs) Table 148. Japan Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 149. South Korea Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 150. India Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 151. Australia Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 152. Taiwan Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 153. Southeast Asia Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 154. SAMEA Pembrolizumab Revenue by Type (2021-2026) & (US$ Million) Table 155. SAMEA Pembrolizumab Revenue by Type (2027-2032) & (US$ Million) Table 156. SAMEA Pembrolizumab Sales by Type (2021-2026) & (k pcs) Table 157. SAMEA Pembrolizumab Sales by Type (2027-2032) & (k pcs) Table 158. SAMEA Pembrolizumab Sales Price by Type (2021-2026) & (US$/pcs) Table 159. SAMEA Pembrolizumab Sales Price by Type (2027-2032) & (US$/pcs) Table 160. SAMEA Pembrolizumab Revenue by Application (2021-2026) & (US$ Million) Table 161. SAMEA Pembrolizumab Revenue by Application (2027-2032) & (US$ Million) Table 162. SAMEA Pembrolizumab Sales by Application (2021-2026) & (k pcs) Table 163. SAMEA Pembrolizumab Sales by Application (2027-2032) & (k pcs) Table 164. SAMEA Pembrolizumab Sales Price by Application (2021-2026) & (US$/pcs) Table 165. SAMEA Pembrolizumab Sales Price by Application (2027-2032) & (US$/pcs) Table 166. SAMEA Pembrolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 167. SAMEA Pembrolizumab Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 168. SAMEA Pembrolizumab Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 169. SAMEA Pembrolizumab Sales by Country (2021 VS 2025 VS 2032) & (k pcs) Table 170. SAMEA Pembrolizumab Sales by Country (2021-2026) & (k pcs) Table 171. SAMEA Pembrolizumab Sales by Country (2027-2032) & (k pcs) Table 172. SAMEA Pembrolizumab Sales Price by Country (2021-2026) & (US$/pcs) Table 173. SAMEA Pembrolizumab Sales Price by Country (2027-2032) & (US$/pcs) Table 174. Brazil Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 175. Argentina Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 176. Chile Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 177. Colombia Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 178. Peru Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 179. Saudi Arabia Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 180. Israel Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 181. UAE Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 182. Turkey Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 183. Iran Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 184. Egypt Pembrolizumab Revenue (2021-2032) & (US$ Million) Table 185. Key Raw Materials Table 186. Raw Materials Key Suppliers Table 187. Pembrolizumab Distributors List Table 188. Pembrolizumab Customers List Table 189. Research Programs/Design for This Report Table 190. Authors List of This Report Table 191. Secondary Sources Table 192. Primary Sources List of Figures Figure 1. Pembrolizumab Image Figure 2. Global Pembrolizumab Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pembrolizumab Market Size Share 2021 VS 2025 VS 2032 Figure 4. 50mg Injection Image Figure 5. 100mg Injection Image Figure 6. Global Pembrolizumab Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Pembrolizumab Market Size Share 2021 VS 2025 VS 2032 Figure 8. Unresectable or Metastatic Solid Tumor Image Figure 9. Advanced Melanoma Image Figure 10. Head and Neck Squamous Cell Carcinoma (HNSCC) Image Figure 11. Others Image Figure 12. Global Pembrolizumab Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Pembrolizumab Revenue (2021-2032) & (US$ Million) Figure 14. Global Pembrolizumab Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Pembrolizumab Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Pembrolizumab Revenue Market Share by Region (2021-2032) Figure 17. Global Pembrolizumab Sales (2021-2032) & (k pcs) Figure 18. Global Pembrolizumab Sales by Region: 2021 VS 2025 VS 2032 (k pcs) Figure 19. Global Pembrolizumab Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Pembrolizumab Sales YoY (2021-2032) & (k pcs) Figure 21. Europe Pembrolizumab Sales YoY (2021-2032) & (k pcs) Figure 22. China Pembrolizumab Sales YoY (2021-2032) & (k pcs) Figure 23. Asia (Excluding China) Pembrolizumab Sales YoY (2021-2032) & (k pcs) Figure 24. South America, Middle East and Africa Pembrolizumab Sales YoY (2021-2032) & (k pcs) Figure 25. Global Pembrolizumab Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Pembrolizumab Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Pembrolizumab Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Pembrolizumab Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Pembrolizumab Revenue Market Share by Type (2021-2032) Figure 31. Global Pembrolizumab Sales by Type (2021 VS 2025 VS 2032) & (k pcs) Figure 32. Global Pembrolizumab Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Pembrolizumab Sales Market Share by Type (2021-2032) Figure 34. Global Pembrolizumab Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Pembrolizumab Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Pembrolizumab Revenue Market Share by Application (2021-2032) Figure 37. Global Pembrolizumab Sales by Application (2021 VS 2025 VS 2032) & (k pcs) Figure 38. Global Pembrolizumab Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Pembrolizumab Sales Market Share by Application (2021-2032) Figure 40. North America Pembrolizumab Revenue Share by Type (2021-2032) Figure 41. North America Pembrolizumab Sales Share by Type (2021-2032) Figure 42. North America Pembrolizumab Revenue Share by Application (2021-2032) Figure 43. North America Pembrolizumab Sales Share by Application (2021-2032) Figure 44. North America Pembrolizumab Revenue Share by Country (2021-2032) Figure 45. North America Pembrolizumab Sales Share by Country (2021-2032) Figure 46. Europe Pembrolizumab Revenue Share by Type (2021-2032) Figure 47. Europe Pembrolizumab Sales Share by Type (2021-2032) Figure 48. Europe Pembrolizumab Revenue Share by Application (2021-2032) Figure 49. Europe Pembrolizumab Sales Share by Application (2021-2032) Figure 50. Europe Pembrolizumab Revenue Share by Country (2021-2032) Figure 51. Europe Pembrolizumab Sales Share by Country (2021-2032) Figure 52. China Pembrolizumab Revenue Share by Type (2021-2032) Figure 53. China Pembrolizumab Sales Share by Type (2021-2032) Figure 54. China Pembrolizumab Revenue Share by Application (2021-2032) Figure 55. China Pembrolizumab Sales Share by Application (2021-2032) Figure 56. Asia Pembrolizumab Revenue Share by Type (2021-2032) Figure 57. Asia Pembrolizumab Sales Share by Type (2021-2032) Figure 58. Asia Pembrolizumab Revenue Share by Application (2021-2032) Figure 59. Asia Pembrolizumab Sales Share by Application (2021-2032) Figure 60. Asia Pembrolizumab Revenue Share by Country (2021-2032) Figure 61. Asia Pembrolizumab Sales Share by Country (2021-2032) Figure 62. SAMEA Pembrolizumab Revenue Share by Type (2021-2032) Figure 63. SAMEA Pembrolizumab Sales Share by Type (2021-2032) Figure 64. SAMEA Pembrolizumab Revenue Share by Application (2021-2032) Figure 65. SAMEA Pembrolizumab Sales Share by Application (2021-2032) Figure 66. SAMEA Pembrolizumab Revenue Share by Country (2021-2032) Figure 67. SAMEA Pembrolizumab Sales Share by Country (2021-2032) Figure 68. Pembrolizumab Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Pembrolizumab Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • 50mg Injection
  • 100mg Injection
Applications
  • Unresectable or Metastatic Solid Tumor
  • Advanced Melanoma
  • Head and Neck Squamous Cell Carcinoma (HNSCC)
  • Others
Companies covered
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Pembrolizumab Market by Type
  3. 1.2.1 Global Pembrolizumab Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 50mg Injection
  5. 1.2.3 100mg Injection
  6. 1.3 Pembrolizumab Market by Application
  7. 1.3.1 Global Pembrolizumab Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Unresectable or Metastatic Solid Tumor
  9. 1.3.3 Advanced Melanoma
  10. 1.3.4 Head and Neck Squamous Cell Carcinoma (HNSCC)
  11. 1.3.5 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Pembrolizumab Market Dynamics
  1. 2.1 Pembrolizumab Industry Trends
  2. 2.2 Pembrolizumab Industry Drivers
  3. 2.3 Pembrolizumab Industry Opportunities and Challenges
  4. 2.4 Pembrolizumab Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Pembrolizumab Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Pembrolizumab Revenue by Region
  3. 3.2.1 Global Pembrolizumab Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Pembrolizumab Revenue by Region (2021-2026)
  5. 3.2.3 Global Pembrolizumab Revenue by Region (2027-2032)
  6. 3.2.4 Global Pembrolizumab Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Pembrolizumab Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Pembrolizumab Sales by Region
  9. 3.4.1 Global Pembrolizumab Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Pembrolizumab Sales by Region (2021-2026)
  11. 3.4.3 Global Pembrolizumab Sales by Region (2027-2032)
  12. 3.4.4 Global Pembrolizumab Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Pembrolizumab Revenue by Manufacturers
  2. 4.1.1 Global Pembrolizumab Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Pembrolizumab Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Pembrolizumab Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Pembrolizumab Sales by Manufacturers
  6. 4.2.1 Global Pembrolizumab Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Pembrolizumab Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Pembrolizumab Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Pembrolizumab Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Pembrolizumab Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Pembrolizumab Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Pembrolizumab Manufacturers, Product Type & Application
  13. 4.7 Global Pembrolizumab Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Pembrolizumab Market CR5 and HHI
  16. 4.8.2 2025 Pembrolizumab Tier 1, Tier 2, and Tier 3
5 Pembrolizumab Market by Type
  1. 5.1 Global Pembrolizumab Revenue by Type
  2. 5.1.1 Global Pembrolizumab Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Pembrolizumab Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Pembrolizumab Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Pembrolizumab Sales by Type
  6. 5.2.1 Global Pembrolizumab Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Pembrolizumab Sales by Type (2021-2032) & (k pcs)
  8. 5.2.3 Global Pembrolizumab Sales Market Share by Type (2021-2032)
  9. 5.3 Global Pembrolizumab Price by Type
6 Pembrolizumab Market by Application
  1. 6.1 Global Pembrolizumab Revenue by Application
  2. 6.1.1 Global Pembrolizumab Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Pembrolizumab Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Pembrolizumab Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Pembrolizumab Sales by Application
  6. 6.2.1 Global Pembrolizumab Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Pembrolizumab Sales by Application (2021-2032) & (k pcs)
  8. 6.2.3 Global Pembrolizumab Sales Market Share by Application (2021-2032)
  9. 6.3 Global Pembrolizumab Price by Application
7 Company Profiles
  1. 7.1 Merck
  2. 7.1.1 Merck Company Information
  3. 7.1.2 Merck Business Overview
  4. 7.1.3 Merck Pembrolizumab Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Merck Pembrolizumab Product Portfolio
  6. 7.1.5 Merck Recent Developments
8 North America
  1. 8.1 North America Pembrolizumab Market Size by Type
  2. 8.1.1 North America Pembrolizumab Revenue by Type (2021-2032)
  3. 8.1.2 North America Pembrolizumab Sales by Type (2021-2032)
  4. 8.1.3 North America Pembrolizumab Price by Type (2021-2032)
  5. 8.2 North America Pembrolizumab Market Size by Application
  6. 8.2.1 North America Pembrolizumab Revenue by Application (2021-2032)
  7. 8.2.2 North America Pembrolizumab Sales by Application (2021-2032)
  8. 8.2.3 North America Pembrolizumab Price by Application (2021-2032)
  9. 8.3 North America Pembrolizumab Market Size by Country
  10. 8.3.1 North America Pembrolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Pembrolizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Pembrolizumab Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Pembrolizumab Market Size by Type
  2. 9.1.1 Europe Pembrolizumab Revenue by Type (2021-2032)
  3. 9.1.2 Europe Pembrolizumab Sales by Type (2021-2032)
  4. 9.1.3 Europe Pembrolizumab Price by Type (2021-2032)
  5. 9.2 Europe Pembrolizumab Market Size by Application
  6. 9.2.1 Europe Pembrolizumab Revenue by Application (2021-2032)
  7. 9.2.2 Europe Pembrolizumab Sales by Application (2021-2032)
  8. 9.2.3 Europe Pembrolizumab Price by Application (2021-2032)
  9. 9.3 Europe Pembrolizumab Market Size by Country
  10. 9.3.1 Europe Pembrolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Pembrolizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Pembrolizumab Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Pembrolizumab Market Size by Type
  2. 10.1.1 China Pembrolizumab Revenue by Type (2021-2032)
  3. 10.1.2 China Pembrolizumab Sales by Type (2021-2032)
  4. 10.1.3 China Pembrolizumab Price by Type (2021-2032)
  5. 10.2 China Pembrolizumab Market Size by Application
  6. 10.2.1 China Pembrolizumab Revenue by Application (2021-2032)
  7. 10.2.2 China Pembrolizumab Sales by Application (2021-2032)
  8. 10.2.3 China Pembrolizumab Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Pembrolizumab Market Size by Type
  2. 11.1.1 Asia Pembrolizumab Revenue by Type (2021-2032)
  3. 11.1.2 Asia Pembrolizumab Sales by Type (2021-2032)
  4. 11.1.3 Asia Pembrolizumab Price by Type (2021-2032)
  5. 11.2 Asia Pembrolizumab Market Size by Application
  6. 11.2.1 Asia Pembrolizumab Revenue by Application (2021-2032)
  7. 11.2.2 Asia Pembrolizumab Sales by Application (2021-2032)
  8. 11.2.3 Asia Pembrolizumab Price by Application (2021-2032)
  9. 11.3 Asia Pembrolizumab Market Size by Country
  10. 11.3.1 Asia Pembrolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Pembrolizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Pembrolizumab Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Pembrolizumab Market Size by Type
  2. 12.1.1 SAMEA Pembrolizumab Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Pembrolizumab Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Pembrolizumab Price by Type (2021-2032)
  5. 12.2 SAMEA Pembrolizumab Market Size by Application
  6. 12.2.1 SAMEA Pembrolizumab Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Pembrolizumab Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Pembrolizumab Price by Application (2021-2032)
  9. 12.3 SAMEA Pembrolizumab Market Size by Country
  10. 12.3.1 SAMEA Pembrolizumab Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Pembrolizumab Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Pembrolizumab Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Pembrolizumab Value Chain Analysis
  2. 13.1.1 Pembrolizumab Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Pembrolizumab Production Mode & Process
  6. 13.2 Pembrolizumab Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Pembrolizumab Distributors
  9. 13.2.3 Pembrolizumab Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst